{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:38:48Z","timestamp":1785847128353,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00432-023-05190-3","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T10:01:56Z","timestamp":1690020116000},"page":"13271-13277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is there any prognostic significance in pleural involvement and\/or effusion in patients with ALK-positive NSCLC?"],"prefix":"10.1007","volume":"149","author":[{"given":"G\u00fcrkan","family":"G\u00fcner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak Yasin","family":"Akta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Bu\u011fdayc\u0131","family":"Ba\u015fal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Demirkaz\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"G\u00fcrsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Erman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perran Fulden","family":"Yumuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz \u00c7ay","family":"\u015eenler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"\u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rfan","family":"\u00c7i\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ak\u0131n","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan \u015eenol","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"\u00c7ubuk\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"I\u015f\u0131kdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer Fatih","family":"\u00d6lmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Murat","family":"Tatl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Karaa\u011fa\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teoman","family":"\u015eakalar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Eralp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadettin","family":"K\u0131l\u0131\u00e7kap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"issue":"10026","key":"5190_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/s0140-6736(16)00004-0","volume":"387","author":"F Barlesi","year":"2016","unstructured":"Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier PP, Lamy R, Beau-Faller M, Zalcman G (2016) Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet 387(10026):1415\u20131426. https:\/\/doi.org\/10.1016\/s0140-6736(16)00004-0","journal-title":"Lancet"},{"issue":"9","key":"5190_CR2","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s00432-021-03546-1","volume":"147","author":"B Bilgin","year":"2021","unstructured":"Bilgin B, \u015eendur MAN, Y\u00fccel \u015e, Hizal M, G\u00fcner G, Aky\u00fcrek N, Erol C, Ak\u0131nc\u0131 MB, Dede D, Yal\u00e7\u0131n B, K\u0131l\u0131\u00e7kap S (2021) The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement. J Cancer Res Clin Oncol 147(9):2637\u20132643. https:\/\/doi.org\/10.1007\/s00432-021-03546-1","journal-title":"J Cancer Res Clin Oncol"},{"issue":"31","key":"5190_CR3","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1200\/jco.20.00505","volume":"38","author":"DR Camidge","year":"2020","unstructured":"Camidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, Lee KH, Delmonte A, Garc\u00eda Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira A, Gettinger SN, Tiseo M, Lin HM, Gupta N, Hanley MJ, Popat S (2020) Brigatinib versus crizotinib in advanced ALK inhibitor-naive ALK-positive non-small cell lung cancer: second interim analysis of the phase III ALTA-1L trial. J Clin Oncol 38(31):3592\u20133603. https:\/\/doi.org\/10.1200\/jco.20.00505","journal-title":"J Clin Oncol"},{"issue":"11","key":"5190_CR4","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1111\/1759-7714.13681","volume":"11","author":"B Campos-Balea","year":"2020","unstructured":"Campos-Balea B, de Castro Carpe\u00f1o J, Massut\u00ed B, Vicente-Baz D, P\u00e9rez Parente D, Ruiz-Gracia P, Crama L, Cobo Dols M (2020) Prognostic factors for survival in patients with metastatic lung adenocarcinoma: an analysis of the SEER database. Thoracic Cancer 11(11):3357\u20133364. https:\/\/doi.org\/10.1111\/1759-7714.13681","journal-title":"Thoracic Cancer"},{"issue":"5","key":"5190_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/cam4.1059","volume":"6","author":"G Chen","year":"2017","unstructured":"Chen G, Chen X, Zhang Y, Yan F, Fang W, Yang Y, Hong S, Miao S, Wu M, Huang X, Luo Y, Zhou C, Gong R, Huang Y, Zhou N, Zhao H, Zhang L (2017) A large, single-center, real-world study of clinicopathological characteristics and treatment in advanced ALK-positive non-small-cell lung cancer. Cancer Med 6(5):953\u2013961. https:\/\/doi.org\/10.1002\/cam4.1059","journal-title":"Cancer Med"},{"issue":"13","key":"5190_CR6","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1158\/0008-5472.Can-07-6158","volume":"68","author":"YL Choi","year":"2008","unstructured":"Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, Kurashina K, Hatanaka H, Ueno T, Takada S, Yamashita Y, Sugiyama Y, Ishikawa Y, Mano H (2008) Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res 68(13):4971\u20134976. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-6158","journal-title":"Cancer Res"},{"issue":"8 Suppl","key":"5190_CR7","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.3.co;2-z","volume":"80","author":"RE Coleman","year":"1997","unstructured":"Coleman RE (1997) Skeletal complications of malignancy. Cancer 80(8 Suppl):1588\u20131594. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19971015)80:8+%3c1588::aid-cncr9%3e3.3.co;2-z","journal-title":"Cancer"},{"issue":"18","key":"5190_CR8","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1002\/cncr.27409","volume":"118","author":"RC Doebele","year":"2012","unstructured":"Doebele RC, Lu X, Sumey C, Maxson DA, Weickhardt AJ, Oton AB, Bunn PA Jr, Bar\u00f3n AE, Franklin WA, Aisner DL, Varella-Garcia M, Camidge DR (2012) Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer. Cancer 118(18):4502\u20134511. https:\/\/doi.org\/10.1002\/cncr.27409","journal-title":"Cancer"},{"issue":"1","key":"5190_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13402-016-0304-6","volume":"40","author":"M Dragoj","year":"2017","unstructured":"Dragoj M, Milosevic Z, Bankovic J, Tanic N, Pesic M, Stankovic T (2017) Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma. Cell Oncol (dordr) 40(1):47\u201362. https:\/\/doi.org\/10.1007\/s13402-016-0304-6","journal-title":"Cell Oncol (dordr)"},{"issue":"5","key":"5190_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1200\/jco.1986.4.5.702","volume":"4","author":"DM Finkelstein","year":"1986","unstructured":"Finkelstein DM, Ettinger DS, Ruckdeschel JC (1986) Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol 4(5):702\u2013709. https:\/\/doi.org\/10.1200\/jco.1986.4.5.702","journal-title":"J Clin Oncol"},{"issue":"1","key":"5190_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11060-004-8093-6","volume":"75","author":"IT Gavrilovic","year":"2005","unstructured":"Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75(1):5\u201314. https:\/\/doi.org\/10.1007\/s11060-004-8093-6","journal-title":"J Neurooncol"},{"issue":"4","key":"5190_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/coc.0000000000000508","volume":"42","author":"R Gupta","year":"2019","unstructured":"Gupta R, Amanam I, Rahmanuddin S, Mambetsariev I, Wang Y, Huang C, Reckamp K, Vora L, Salgia R (2019) Anaplastic Lymphoma Kinase (ALK)-positive tumors: clinical, radiographic and molecular profiles, and uncommon sites of metastases in patients with lung adenocarcinoma. Am J Clin Oncol 42(4):337\u2013344. https:\/\/doi.org\/10.1097\/coc.0000000000000508","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"5190_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1200\/jco.2005.04.177","volume":"23","author":"T Hoang","year":"2005","unstructured":"Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH (2005) Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol 23(1):175\u2013183. https:\/\/doi.org\/10.1200\/jco.2005.04.177","journal-title":"J Clin Oncol"},{"issue":"2","key":"5190_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1200\/jco.2015.62.0138","volume":"34","author":"KL Johung","year":"2016","unstructured":"Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN (2016) Extended survival and prognostic factors for patients with ALK-rearranged non-small-cell lung cancer and brain metastasis. J Clin Oncol 34(2):123\u2013129. https:\/\/doi.org\/10.1200\/jco.2015.62.0138","journal-title":"J Clin Oncol"},{"issue":"14","key":"5190_CR15","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.7150\/jca.30463","volume":"10","author":"J Li","year":"2019","unstructured":"Li J, Zhu H, Sun L, Xu W, Wang X (2019) Prognostic value of site-specific metastases in lung cancer: a population based study [Research Paper]. J Cancer 10(14):3079\u20133086. https:\/\/doi.org\/10.7150\/jca.30463","journal-title":"J Cancer"},{"issue":"1\u20132","key":"5190_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0304-3959(96)03267-8","volume":"69","author":"S Mercadante","year":"1997","unstructured":"Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69(1\u20132):1\u201318. https:\/\/doi.org\/10.1016\/s0304-3959(96)03267-8","journal-title":"Pain"},{"issue":"3","key":"5190_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ejcts.2008.05.016","volume":"34","author":"T Nakagawa","year":"2008","unstructured":"Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K (2008) Postrecurrence survival in patients with stage I non-small cell lung cancer. Eur J Cardiothorac Surg 34(3):499\u2013504. https:\/\/doi.org\/10.1016\/j.ejcts.2008.05.016","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"5190_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/thx.29.1.132","volume":"29","author":"WI Onuigbo","year":"1974","unstructured":"Onuigbo WI (1974) Contralateral pulmonary metastases in lung cancer. Thorax 29(1):132\u2013133. https:\/\/doi.org\/10.1136\/thx.29.1.132","journal-title":"Thorax"},{"issue":"9","key":"5190_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1704795","volume":"377","author":"S Peters","year":"2017","unstructured":"Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim D-W, Ou S-HI, P\u00e9rol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T (2017) Alectinib versus crizotinib in untreated ALK-positive non\u2013small-cell lung cancer. N Engl J Med 377(9):829\u2013838. https:\/\/doi.org\/10.1056\/NEJMoa1704795","journal-title":"N Engl J Med"},{"issue":"2","key":"5190_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.lungcan.2013.07.025","volume":"82","author":"LA Pikor","year":"2013","unstructured":"Pikor LA, Ramnarine VR, Lam S, Lam WL (2013) Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer 82(2):179\u2013189. https:\/\/doi.org\/10.1016\/j.lungcan.2013.07.025","journal-title":"Lung Cancer"},{"issue":"1","key":"5190_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/0003-4975(96)00220-2","volume":"62","author":"LE Quint","year":"1996","unstructured":"Quint LE, Tummala S, Brisson LJ, Francis IR, Krupnick AS, Kazerooni EA, Iannettoni MD, Whyte RI, Orringer MB (1996) Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 62(1):246\u2013250. https:\/\/doi.org\/10.1016\/0003-4975(96)00220-2","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"5190_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00330-015-3814-0","volume":"26","author":"S Rizzo","year":"2016","unstructured":"Rizzo S, Petrella F, Buscarino V, De Maria F, Raimondi S, Barberis M, Fumagalli C, Spitaleri G, Rampinelli C, De Marinis F, Spaggiari L, Bellomi M (2016) CT Radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer. Eur Radiol 26(1):32\u201342. https:\/\/doi.org\/10.1007\/s00330-015-3814-0","journal-title":"Eur Radiol"},{"issue":"21","key":"5190_CR23","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","volume":"383","author":"AT Shaw","year":"2020","unstructured":"Shaw AT, Bauer TM, de Marinis F, Felip E, Goto Y, Liu G, Mazieres J, Kim DW, Mok T, Polli A, Thurm H, Calella AM, Peltz G, Solomon BJ (2020) First-line lorlatinib or crizotinib in advanced ALK-positive lung cancer. N Engl J Med 383(21):2018\u20132029. https:\/\/doi.org\/10.1056\/NEJMoa2027187","journal-title":"N Engl J Med"},{"issue":"7","key":"5190_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/s1470-2045(17)30339-x","volume":"18","author":"AT Shaw","year":"2017","unstructured":"Shaw AT, Kim TM, Crin\u00f2 L, Gridelli C, Kiura K, Liu G, Novello S, Bearz A, Gautschi O, Mok T, Nishio M, Scagliotti G, Spigel DR, Deudon S, Zheng C, Pantano S, Urban P, Massacesi C, Viraswami-Appanna K, Felip E (2017) Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 18(7):874\u2013886. https:\/\/doi.org\/10.1016\/s1470-2045(17)30339-x","journal-title":"Lancet Oncol"},{"issue":"1","key":"5190_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9\u201329. https:\/\/doi.org\/10.3322\/caac.21208","journal-title":"CA Cancer J Clin"},{"issue":"7153","key":"5190_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S-I, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H (2007) Identification of the transforming EML4\u2013ALK fusion gene in non-small-cell lung cancer. Nature 448(7153):561\u2013566. https:\/\/doi.org\/10.1038\/nature05945","journal-title":"Nature"},{"issue":"23","key":"5190_CR27","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ, Mok T, Kim D-W, Wu Y-L, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Iyer S, Reisman A, Wilner KD, Tursi J, Blackhall F (2014) First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371(23):2167\u20132177. https:\/\/doi.org\/10.1056\/NEJMoa1408440","journal-title":"N Engl J Med"},{"issue":"9","key":"5190_CR28","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1200\/jco.1988.6.9.1474","volume":"6","author":"JB S\u00f8rensen","year":"1988","unstructured":"S\u00f8rensen JB, Hansen HH, Hansen M, Dombernowsky P (1988) Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 6(9):1474\u20131480. https:\/\/doi.org\/10.1200\/jco.1988.6.9.1474","journal-title":"J Clin Oncol"},{"issue":"5","key":"5190_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jtho.2016.03.012","volume":"11","author":"AS Tsao","year":"2016","unstructured":"Tsao AS, Scagliotti GV, Bunn PA Jr, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam SS, Gomez DR, Rosenzweig KE, Zimmermann S, Pass HI (2016) Scientific advances in lung cancer 2015. J Thorac Oncol 11(5):613\u2013638. https:\/\/doi.org\/10.1016\/j.jtho.2016.03.012","journal-title":"J Thorac Oncol"},{"key":"5190_CR30","unstructured":"Varella-Garcia MIJ, Pao W (2011) ALK fusion and MET amplification as molecular biomarkers and therapeutic targets in advanced lung adenocarcinomas in the Lung Cancer Mutation Consortium. J Thorac Oncol 6(6): S291"},{"issue":"4","key":"5190_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3892\/ijo.15.4.737","volume":"15","author":"N Yamamoto","year":"1999","unstructured":"Yamamoto N, Tamura T, Fukuoka M, Saijo N (1999) Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience. Int J Oncol 15(4):737\u2013741. https:\/\/doi.org\/10.3892\/ijo.15.4.737","journal-title":"Int J Oncol"},{"issue":"6","key":"5190_CR32","first-page":"S50","volume":"6","author":"P Yang","year":"2011","unstructured":"Yang P (2011) Lung cancer in never-smokers: prognostic implications. J Thorac Oncol 6(6):S50","journal-title":"J Thorac Oncol"},{"issue":"5","key":"5190_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13402-017-0345-5","volume":"40","author":"M Yousefi","year":"2017","unstructured":"Yousefi M, Bahrami T, Salmaninejad A, Nosrati R, Ghaffari P, Ghaffari SH (2017) Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options. Cell Oncol (dordr) 40(5):419\u2013441. https:\/\/doi.org\/10.1007\/s13402-017-0345-5","journal-title":"Cell Oncol (dordr)"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05190-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T08:14:27Z","timestamp":1697703267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05190-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["5190"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05190-3","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"27 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the institutional review boards at each of the participating centers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}